2F5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Scinai Immunotherapeutics Ltd

Watchlist Manager

Watchlist

Price: 2.26 EUR 900%

Market Cap: €31.4B

	Scinai Immunotherapeutics Ltd F:2F5	IL
Q	Quebec Nickel Corp F:7IB	CA
T	Transcontinental Inc OTC:TCLCF	CA
	Pro DV AG F:PDA	DE
	Belluna Co Ltd F:73L	JP
L	LiqTech International Inc F:39J	DK
	First Pacific Co Ltd F:FPC	HK
	Highbank Resources Ltd F:V7O0	CA
	Straits Trading Company Ltd F:W2F	SG

Profitability Summary

Scinai Immunotherapeutics Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-196%

Negative 3Y Average Gross Margin

-130%

Negative Operating Margin

-535%

Negative 3Y Average Operating Margin

-1.078%

Negative Net Margin

-345%

Negative 3Y Average Net Margin

-65%

Negative Free Cash Flow Margin

-292%

Negative 3Y Average Free Cash Flow Margin

-1.215%

Negative ROE

-82%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-66%

Declining ROIC

-92% > -110%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.